肝门部胆管癌的外科治疗

Surgical treatment of hilar cholangiocarcionma

目的探讨肝门部胆管癌治疗方法。方法肝门部胆管癌切除者行高位胆肠Roux-en-Y吻合术,未切除者行胆汁内或外引流术,或行PTCD。结果共有39例予以切除。其中,27例切除后生存在18个月以上;39例术后血清胆红素均降至正常水平。结论肝门部胆管癌外科手术治疗是主要手段。肝门部胆管癌应争取手术切除,合理的联合肝叶切除能提高根治性切除率,改善预后。

Objective To study the effective thereapeutic method of hepartic portal cholangiocarcinoma. Methods Cholangiojejunostomy was performed on the patients who underwent excision of the tumor. Results Of 39 cases underwent excision,27 patients were survived over 18 months. Hemobilirubins of all patients underwent excision decreased to the normal level after operation. Conclusion Surgical resection is still a choice for the treatment of hilar cholangiocarcinoma, which combined with hepatectomy could increase radical resection rate and improve patient＇s prognosis.